NVCR

NovoCure Ltd

NasdaqAdd to watchlist

Healthcare · Medical Devices

$17.82

−$0.17−0.94%

Delayed · 2026-08-28T20:00:00.000Z · marketstack

1 of 47tracked managers hold this· Q2 2026

Aug 11, 2026$17.82

+$0.16+0.91%over 1M

Day range54% of range

$17.42$18.16

Session

Previous close: $17.99
Open: $17.99
Volume: 855.6K
Avg volume: -
Day high: $18.16
Day low: $17.42

Fundamentals

Visualize fundamentals and more

Market cap: 2.07B
P/E ratio: -
EPS (TTM): -$1.28
Dividend yield: -
Beta: 1.06
Shares outstanding: 116.01M

Source SEC EDGAR · 9/11/2026

Tracked investors

As of Q2 2026 · 73 days ago · next update ~14 Nov 2026· what moved this quarter, onMeasure

1 fund manager this platform follows disclosed a position in NVCR, from quarterly SEC filings up to 45 days old; a manager may have sold since without yet having to say so.

Baillie Gifford
Baillie Gifford & Co
$14.42M
0.01%of book

Manager	Position	Share of their book	Last change
Baillie Gifford Baillie Gifford & Co	$14.42M	0.01%

Share price, with each quarter a tracked manager’s position changed shaded across the range it traded in.

8162432

now

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Q3 '25

Q4 '25

Q1 '26

Q2 '26

Hover a shaded quarter to see it moved. Who, and the range they traded in, is onBespoke

13F filings cover US-listed shares only (not cash, bonds, shorts, or private holdings) and are never a recommendation to do the same.

Risk factors, year on year

Item 1AFebruary 2026 10-KFebruary 2025as filed.

added: 17
dropped: 26
re-drafted: 27

Out of 212 passages in this year’s Item 1A.

The assistant has not been given these passages. It will say so, and say what opens them. This costs you no question.

New this year

Clinical testing can be costly and take many years, and the outcome is uncertain and susceptible to varying interpretations. Moreover, success in preclinical and early clinical studies does not ensure that large-scale studies will be successful or predict …

42 more passages, included withBespoke

Recent activity

Sep 9Leadership changeCompany filing8-K

27 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like NovoCure Ltd

Also filed under Medical Devices, ranked by how closely they sit beside NVCR.

BSXBOSTON SCIENTIFIC CORP
SYKSTRYKER CORP
ABTABBOTT LABORATORIES
MDTMedtronic plc
DXCMDEXCOM INC
PODDINSULET CORP

Ask about NovoCure Ltd

The assistant answers from what NVCR has actually filed: 13 annual reports filed with the SEC, 60 Form 4 filings from the last year, 13F positions from the 1 tracked investor who hold it and 4 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from NVCR's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding NovoCure Ltd, and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with NovoCure Ltd

Separate the decisions from the paperwork
Every Form 4 NVCR insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about NovoCure Ltd's fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.